Ozempic now shows promising results for Type 1 diabetes – with 36% of patients hitting all treatment targets compared to ZERO in the placebo group.

Karmactive Staff

The 26-week study focused on Type 1 diabetes patients with obesity using automated insulin delivery systems – a growing demographic facing unique challenges.

Photo Source: Egor Kamelev (Pexels)

Patients taking Ozempic lost an average of 20 pounds while maintaining better blood sugar control – potentially addressing the complex issue of "double diabetes."

Photo Credit: Anna Tarazevich (Pexels)

"For a hundred years, we are fixated on insulin and insulin delivery...and there aren't really extra medications approved for type 1," explains lead researcher Dr. Viral Shah.

Photo Source: HualinXMN (CC BY-SA 4.0)

How does Ozempic work differently from insulin? It mimics a hormone called GLP-1 that slows digestion, reduces liver sugar production, and improves insulin sensitivity.

Photo Source: Дело Вкуса, (CC0)

While insulin remains essential for Type 1 diabetes, Ozempic could become the first approved add-on medication to help those who also struggle with obesity.

Photo Source: chemist4u (CC BY-SA 2.0)

The risk of severe low blood sugar didn't increase with Ozempic – with only two cases reported in both treatment and placebo groups.

Photo Source: chemist4u (CC BY-SA 2.0)

Despite these promising results, the FDA hasn't approved Ozempic for Type 1 diabetes yet – larger trials are needed before it becomes widely available.

Photo Credit: Josef Reischig (CC BY 3.0)

Dr. Ahmad Haidar from McGill University called the study "an important stepping stone" but cautioned that "we need more evidence" for regulatory approval.

Photo Source: Internet Archive Book Images (CC0 1.0)

Could this be the first significant treatment advance beyond insulin in a century for Type 1 diabetes patients? Researchers hope pharmaceutical companies will now conduct larger approval trials.

Photo Source: chemist4u (CC BY-SA 2.0)